A detailed history of Nisa Investment Advisors, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 142 shares of ALEC stock, worth $646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142
Previous 49 189.8%
Holding current value
$646
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$4.19 - $6.23 $389 - $579
93 Added 189.8%
142 $0
Q1 2024

May 01, 2024

BUY
$5.69 - $8.08 $278 - $395
49 New
49 $0
Q2 2023

Aug 11, 2023

BUY
$5.86 - $7.93 $322 - $436
55 New
55 $0
Q3 2022

Nov 07, 2022

SELL
$8.19 - $13.2 $2,760 - $4,448
-337 Reduced 84.25%
63 $1,000
Q2 2022

Aug 03, 2022

BUY
$7.65 - $14.24 $3,060 - $5,696
400 New
400 $4,000
Q4 2021

Feb 03, 2022

SELL
$19.35 - $25.54 $47,407 - $62,573
-2,450 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$15.5 - $22.48 $37,975 - $55,076
2,450 New
2,450 $51,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $376M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.